IRIS
FAVOINO, ELVIRA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.221
EU - Europa 777
AS - Asia 444
Continente sconosciuto - Info sul continente non disponibili 1
SA - Sud America 1
Totale 4.444
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.219
CN - Cina 294
IT - Italia 277
SE - Svezia 211
SG - Singapore 109
UA - Ucraina 74
DE - Germania 66
FI - Finlandia 56
GB - Regno Unito 42
FR - Francia 26
IN - India 21
VN - Vietnam 14
BE - Belgio 12
IE - Irlanda 5
NL - Olanda 4
ID - Indonesia 2
AL - Albania 1
AZ - Azerbaigian 1
BZ - Belize 1
CL - Cile 1
CR - Costa Rica 1
EU - Europa 1
GR - Grecia 1
HR - Croazia 1
IM - Isola di Man 1
JP - Giappone 1
PH - Filippine 1
TR - Turchia 1
Totale 4.444
Salva come PNG Salva come JPEG
Città #
Fairfield 421
Chandler 311
Woodbridge 263
Houston 246
Ashburn 243
Jacksonville 206
Ann Arbor 189
Nyköping 186
Cambridge 184
Bari 178
Seattle 178
Wilmington 166
Singapore 95
Nanjing 72
Beijing 66
Roxbury 63
Lawrence 60
Boardman 49
Des Moines 41
Princeton 36
Inglewood 34
New York 31
Dearborn 22
Pune 20
Shenyang 19
San Diego 16
Brooklyn 15
Dong Ket 14
Paris 14
Noicattaro 13
Brussels 12
Nanchang 11
Santa Clara 11
Guangzhou 10
Tianjin 10
Hebei 9
Los Angeles 8
Rome 8
Changsha 7
Indiana 6
Jiaxing 6
London 6
San Francisco 6
Auburn Hills 5
Dublin 5
Kunming 5
Turin 5
Wuhan 5
Falls Church 4
Kilburn 4
Marseille 4
Munich 4
Washington 4
West Jordan 4
Hefei 3
Helsinki 3
Jinan 3
Redmond 3
Redwood City 3
Shanghai 3
Acquaviva Picena 2
Acton 2
Amsterdam 2
Arzano 2
Canosa Di Puglia 2
Catanzaro 2
Durham 2
Florence 2
Foshan 2
Haikou 2
Napoli 2
New Bedfont 2
Ningbo 2
Norwalk 2
Romola 2
Tappahannock 2
Wuxi 2
Aci Catena 1
Atlanta 1
Augusta 1
Bitritto 1
Buffalo 1
Chiswick 1
Chongqing 1
Dallas 1
Dangriga 1
Douglas 1
Edinburgh 1
Esslingen am Neckar 1
Frankfurt am Main 1
Heze 1
Hounslow 1
Islington 1
Jinhua 1
Manila 1
Monmouth Junction 1
New Delhi 1
Novara 1
Padova 1
Phoenix 1
Totale 3.685
Salva come PNG Salva come JPEG
Nome #
Evaluation of the influence of social, demographic, environmental, work-related factors and/or lifestyle habits on Raynaud's phenomenon: a case-control study 139
Anti-carbamylated protein antibodies and skin involvement in patients with systemic sclerosis: An intriguing association 123
CD20-Mimotope Peptides: A Model to Define the Molecular Basis of Epitope Spreading 123
Clinical correlates of human leucocyte antigen (HLA)-G in systemic sclerosis 121
Anti-centromere protein A antibodies in systemic sclerosis: Significance and origin 116
ANTIBODIES TO ENDOPLASMIN AND THEIR USE 115
Autoantibodies Recognizing the Amino Terminal 1-17 Segment of CENP-A Display Unique Specificities in Systemic Sclerosis 113
Methods for treating a tumor using an antibody that specifically binds HMW-MAA 107
Clinical correlates of a subset of anti-CENP-A antibodies cross-reacting with FOXE3p53-62 in systemic sclerosis 105
Oxidized low density lipoproteins: The bridge between atherosclerosis and autoimmunity. Possible implications in accelerated atherosclerosis and for immune intervention in autoimmune rheumatic disorders. 105
CD20-Mimotope Peptide Active Immunotherapy in Systemic Lupus Erythematosus and a Reappraisal of Vaccination Strategies in Rheumatic Diseases 103
The CSPG4-specific monoclonal antibody enhances and prolongs the effects of the BRAF inhibitor in melanoma cells 99
AB0695 Subspecificities of Anti-Centromeric-Associated Protein a (CENP-A) Antibodies (AB) Can Identified a Subset of Patients at Higher Risk of Developing Pulmonary Hypertension 96
Subspecificities of anticentromeric protein A antibodies identify systemic sclerosis patients at higher risk of pulmonary vascular disease 94
CD20 mimicry by a mAb rituximab-specific linear peptide: A potential tool for active immunotherapy of autoimmune diseases 89
Generation of biologically active linear and cyclic peptides has revealed a unique fine specificity of rituximab and its possible cross-reactivity with acid sphingomyelinase-like phosphodiesterase 3b precursor 86
CD20: A target antigen for immunotherapy of autoimmune diseases 86
Working and safety profiles of JAK/STAT signaling inhibitors. Are these small molecules also smart? 86
Rheumatic disorders as paraneoplastic syndromes 85
Novel combinatorial therapy for pancreatic adenocarcinoma 83
Effects of Adjuvants for Human Use in Systemic Lupus Erythematosus (Sle)-Prone (Nzb/Nzw) F1 Mice 80
CD20 mimicry by mAb Rituximab-specific linear peptide. A potential tool for active immunotherapy of autoimmune diseases 80
Two structurally different rituximab-specific CD20 mimotope peptides reveal that rituximab recognizes two different CD20-associated epitopes 79
Abstract 4390: Heat shock protein (HSP) Grp94-targeted combinatorial immunotherapy for pancreatic cancer 78
null 77
HLA class I downregulation is associated with enhanced NK-cell killing of melanoma cells with acquired drug resistance to BRAF inhibitors 74
Biological therapy with monoclonal antibodies: a novel treatment approach to autoimmune disease 73
Targeting cancer initiating cells in pancreatic adenocarcinoma 70
Response to "Is active acid sphingomyelinase required for the antiproliferative response to rituximab?" [e-letter]. http://bloodjournal.hematologylibrary.org/content/117/13/3695.citation/reply#bloodjournal_el_2268 69
Low mortality rate in Italian rheumatoid arthritis patients from a tertiary center: Putative implication of a low anti-carbamylated protein antibodies prevalence 69
Functional characterization of an scFv-Fc antibody that immunotherapeutically targets the common cancer cell surface proteoglycan CSPG4 68
Identification of an antigenic and immunogenic motif expressed by two 7-mer rituximab-specific cyclic peptide mimotopes: Implication for peptide-based active immunotherapy 67
Anti-carbamylated protein antibodies in patients with systemic sclerosis: an intriguing association with skin involvement 67
CSPG4 in cancer: Multiple roles 66
Tumor Antigen-Specific Monoclonal Antibody-Based Immunotherapy, Cancer Initiating Cells and Disease Recurrence 66
Identification of an antigenic and immunogenic motif expressed by two 7-Mer Rituximab-specific cyclic peptides 64
Beta2-microglobulin-free HLA class I heavy chain epitope mimicry by monoclonal antibody HC-10-specific peptide 60
Antitumor activity of BRAF inhibitor and IFN×alpha; Combination in BRAF-mutant melanoma 60
Identificazione del peptide che mima l'epitopo localizzato sulla catena pesante HLA-I non associata alla beta 2-microglobulina, riconosciuto dall'anticorpo monoclonale HC-10 58
SARS-CoV-2 infection complicated by inflammatory syndrome. Could high-dose human immunoglobulin for intravenous use (IVIG) be beneficial? 58
EXPRESSION OF THE TRANSCRIPTION FACTOR FORKHEAD BOX E3 (FOXE3) IN PERIPHERAL BLOOD MONONUCLEAR CELLS OF PATIENTS WITH SYSTEMIC SCLEROSIS 57
Staging multiple myeloma patients with active disease using serum levels of beta2m-free HLA class I heavy chain together with IgM or platelet count 56
Human CD4 mimicry by anti-idiotypic monoclonal antibody 16D7 is based on a conformational epitope 56
Sars-cov-2 inflammatory syndrome. Clinical features and rationale for immunological treatment 56
Harnessing host innate immunity may combat acquired resistance to BRAFi 54
Dietary cholesterol supplementation and inhibitory factor 1 serum levels in two dizygotic Smith-Lemli-Opitz syndrome twins: a case report 53
EXPRESSION OF THE TRANSCRIPTION FACTOR FORKHEAD BOX E3 (FOXE3) IN MONOCYTES FROM PATIENTS WITH SYSTEMIC SCLEROSIS AND CORRELATION WITH THEIR SEROLOGICAL PROFILE 48
null 48
Metodo ELISA: dosaggio della catena pesante della molecola HLA non associata alla b2-microglobulina 45
AUTO-ANTIBODIES TO THE AMINO TERMINAL SEGMENT (AMINOACID 1-17) OF CENP-A DISPLAY A UNIQUE SPECIFICITY IN SYSTEMIC SCLEROSIS AND ARE INDEPENDENTLY EXPRESSED FROM THOSE AGAINST CENP-B 45
Insight into the specificità of the anti-CD20 monclonal antibody Rituximab. 44
Poems syndrome with amyloidosis and calchyphylaxis.A case report 43
Peptidi che mimano l'antigene CD20: potenzialità terapeutiche nel lupus eritematoso sistemico 42
Characterization of the specificity of the Human scFv W9 42
Ruolo degli autoanticorpi nelle patologie autoimmuni 36
Quantitative evaluation of anti-FOXE-3 Ab identifies a subset of anti-CENP positive systemic sclerosis patients who are less prone to develop active disease 34
null 33
Phlegmonous abscess associated with etanercept therapy 33
Raynaud’s phenomenon: from molecular pathogenesis to therapy 31
Two structurally different peptides mimic a CD20 epitope recognized by rituximab 30
Functional characterization of peptides mimicking the CD20 epitope recognized by Rituximab 30
Generation of linear and cyclic peptides revealed a unique fine specificity of Rituximab and its possible cross-reactivity with an acid sphingomyelinase-like phosphodiesterasem 3B precursor 28
Mimotope peptides in the immunization against CD20: a promising approach to the therapy of autoimmune diseases 27
Identification of an antigenic and immunogenic motif expressed by two 7-Mer Rituximab-specific cyclic peptides. Journal of Immunology 27
 Peptides highly specific to the variable region of TNF-ALFA-specific references licensed (RL) monoclonal antibodies (MAB), as potential tool to effectively assess similarity between biosimilars and the correspondig RL MAB 27
Circulating Inhibitory Factor 1 levels in adult patients with Prader-Willi syndrome 25
Ruolo degli autoanticorpi nelle patologie autoimmuni 22
Why Do We Still Lack a COVID-19 Vaccine? Searching for the Missing Pieces 20
Novel biomarker for pulmonary vascular disease in systemic sclerosis patients 18
Circulating Irisin Levels in Patients with Chronic Plaque Psoriasis. 17
Methods for treating a tumor using an antibody that specifically binds grp94 13
Functional characterization of peptides mimicking the CD-20 epitope recognized by Rituximab 12
Chronic-Relapsing cutaneous leukocytoclastic vasculitis in a young patient with reduced EBV-specific T cell response using enzyme-linked immunospot (ELISPOT) assay successfully treated with Valaciclovir 10
Systemic sclerosis and primary biliary cholangitis share an antibody population with identical specificity 9
Impact of belimumab therapy on the quality of life in patients with systemic lupus erythematosus: A cohort study 7
Clinical correlates of a subset of anti-fibroblast antibodies in systemic sclerosis 6
HLA allele prevalence in disease-modifying antirheumatic drugs-responsive enthesitis and/or arthritis not fulfilling ASAS criteria: Comparison with psoriatic and undifferentiated spondyloarthritis 5
Grp94-specific monoclonal antibody to counteract BRAF inhibitor resistance in BRAFV600E melanoma 5
β2-microglobulin-free HLA class I heavy chain epitope mimicry by monoclonal antibody HC-10-specific peptide 5
Endothelial cells in tumor microenvironment: insights and perspectives 4
Clinical and subclinical atherosclerosis in patients with systemic sclerosis: an observational, multicentre study of GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) 4
Classic pyoderma gangrenosum 3
Idiopathic and connective tissue disease-associated pulmonary arterial hypertension (PAH): Similarities, differences and the role of autoimmunity 2
Totale 4.669
Salva come PNG Salva come JPEG
Categoria #
all - tutte 20.287
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.287
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020709 0 0 0 0 135 108 98 75 111 54 110 18
2020/2021766 69 21 60 29 116 50 131 83 62 75 36 34
2021/2022522 24 67 6 18 22 34 51 22 32 23 97 126
2022/2023844 122 94 45 74 107 105 29 116 113 9 16 14
2023/2024363 24 53 19 70 21 77 11 21 8 8 6 45
2024/2025259 79 18 114 20 28 0 0 0 0 0 0 0
Totale 4.669